Michael Mamoun, M.D.

 

Michael Mamoun

Michael Mamoun, M.D.

Executive Medical Director
Board Certified in General & Adult Psychiatry

Michael Mamoun, M.D. is a physician who is board certified in psychiatry. Doctor Mamoun completed his residency training at the Neuropsychiatric Institute of the UCLA Medical Center. UCLA is consistently ranked in the top 10 institutions for psychiatry in the U.S.

Although Dr. Mamoun has extensive expertise in the treatment of ADHD, anxiety, and mood disorders, he is skilled in treating the entire spectrum of mental health conditions. Dr. Mamoun has treated a wide range of patients in multiple clinical settings including: private practice, UCLA and other university medical centers,  multiple veterans’ medical centers, county and public mental health clinics, non-profit medical and mental health clinics, and community hospitals. He has previously served as the Director of Psychiatric Services at Homeless Healthcare Los Angeles and has volunteered at the non-profit Venice Family Clinic. Originally from Chicago, Dr. Mamoun attended college and medical school at the University of Illinois.

Doctor Mamoun is also actively involved in bio-medical research. His main work is through the Brentwood Biomedical Research Institute in affiliation with the UCLA and VA Medical Centers. His past and ongoing research projects utilize brain imaging to better understand the nature and treatment of tobacco dependence and smoking cessation technology.

 

Link to Patient Reviews on Vitals.com
Link to Patient Reviews on Yelp.com
Link to Patient Reviews on Healthgrades.com

 Link to Recent Research Studies on ResearchGate

 

Recently published research studies:

August 2014:
Radiation dosimetry and biodistribution of the translocator protein radiotracer [(11)C]DAA1106 determined with PET/CT in healthy human volunteers.
Nuclear Medicine and Biology
Link

May 2014:
Brain Nicotinic Acetylcholine Receptor Availability and Response to Smoking Cessation Treatment: A Randomized Trial.
JAMA (Journal of the American Medical Association) Psychiatry. MRI & PET brain imaging study.
Link

July 2013:
Treatment for tobacco dependence: effect on brain nicotinic acetylcholine receptor density.
Neuropsychopharmacology. 2013 Jul;38(8):1548-56.  PET neuroimaging study.
Link

June 2013:
Up-regulation of nicotinic acetylcholine receptors in menthol cigarette smokers
International Journal of Neuropsychopharmacology. 2013 Jun;16(5):957-66. PET neuroimaging study.
Link

 

 

patients choice awards

 

usnews